U-SPECT-BioFluo: an integrated radionuclide, bioluminescence, and fluorescence imaging platform The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation van Oosterom, Matthias N, Rob Kreuger, Tessa Buckle, Wendy A Mahn, Anton Bunschoten, Lee Josephson, Fijs WB van Leeuwen, and Freek J Beekman. 2014. “U-SPECT-BioFluo: an integrated radionuclide, bioluminescence, and fluorescence imaging platform.” EJNMMI Research 4 (1): 56. doi:10.1186/s13550-014-0056-0. http:// dx.doi.org/10.1186/s13550-014-0056-0. Published Version doi:10.1186/s13550-014-0056-0 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:13454830 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA van Oosterom et al. EJNMMI Research 2014, 4:56 http://www.ejnmmires.com/content/4/1/56 ORIGINAL RESEARCH Open Access U-SPECT-BioFluo: an integrated radionuclide, bioluminescence, and fluorescence imaging platform Matthias N van Oosterom1,2, Rob Kreuger1*, Tessa Buckle2, Wendy A Mahn1, Anton Bunschoten2, Lee Josephson3, Fijs WB van Leeuwen2 and Freek J Beekman1,4,5 Abstract Background: In vivo bioluminescence, fluorescence, and single-photon emission computed tomography (SPECT) imaging provide complementary information about biological processes. However, to date these signatures are evaluated separately on individual preclinical systems. In this paper, we introduce a fully integrated bioluminescence-fluorescence-SPECT platform. Next to an optimization in logistics and image fusion, this integration can help improve understanding of the optical imaging (OI) results. Methods: An OI module was developed for a preclinical SPECT system (U-SPECT, MILabs, Utrecht, the Netherlands). The applicability of the module for bioluminescence and fluorescence imaging was evaluated in both a phantom and in an in vivo setting using mice implanted with a 4 T1-luc + tumor. A combination of a fluorescent dye and radioactive moiety was used to directly relate the optical images of the module to the SPECT findings. Bioluminescence imaging (BLI) was compared to the localization of the fluorescence signal in the tumors. Results: Both the phantom and in vivo mouse studies showed that superficial fluorescence signals could be imaged accurately. The SPECT and bioluminescence images could be used to place the fluorescence findings in perspective, e.g. by showing tracer accumulation in non-target organs such as the liver and kidneys (SPECT) and giving a semi-quantitative read-out for tumor spread (bioluminescence). Conclusions: We developed a fully integrated multimodal platform that provides complementary registered imaging of bioluminescent, fluorescent, and SPECT signatures in a single scanning session with a single dose of anesthesia. In our view, integration of these modalities helps to improve data interpretation of optical findings in relation to radionuclide images. Keywords: Bioluminescence imaging; Fluorescence imaging; Multimodal molecular imaging; SPECT; Small animal; Nuclear medicine Background provide a means to generate a view into the in vivo situ- Studies of human disease in animal models often pro- ation [1,2]. vide an essential link between chemistry, fundamental SPECT and optical technologies are complementary in research at the molecular level, and the development/ terms of resolution, speed, quantitative accuracy, and evaluation of new diagnostic and therapeutic methods. tracer availability [3-5]. Independent of the source depth, Molecular imaging modalities such as single-photon emis- modern small animal SPECT systems can be used for sion computed tomography (SPECT), positron emission longitudinal and quantitative imaging studies of dynamic tomography (PET), bioluminescence, and fluorescence processes in small structures (resolution <0.25 mm) [6]. Alternatively, optical imaging provides a rapid and low- cost non-radioactive imaging and enables longitudinal * Correspondence: [email protected] 1Radiation, Detection and Medical Imaging, Delft University of Technology, studies of superficial lesions. The resolution of fluores- Mekelweg 15, 2629 JB, Delft, the Netherlands cence imaging also enables the (ex vivo) microscopic Full list of author information is available at the end of the article © 2014 van Oosterom et al.; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. van Oosterom et al. EJNMMI Research 2014, 4:56 Page 2 of 11 http://www.ejnmmires.com/content/4/1/56 visualization of molecular/cellular processes [7]. Poten- for a dedicated small animal SPECT device (U-SPECT- tially, a vast amount of optical tracers from molecular II, MILabs B.V., Utrecht, the Netherlands) [21-24]. cell biology can be translated to in vivo use. Alternative to a use in combination with dedicated tracers, optical Methods imaging can also be used to detect transfected (tumor) Optical module for small animal SPECT cell lines that contain e.g. luciferase or one of the fluor- The prototype optical imaging (OI) module was fitted escent proteins [8], enabling the (longitudinal) monitor- onto the U-SPECT-II [21,22] installed at the LUMC ing of disease spread and progression in animal models. (Leiden, the Netherlands) as is shown in Figure 1. The The main disadvantages for optical techniques are the optical module consists of three main components: 1) a significant scatter and absorption of photons by tissue/ light tight ‘dark box’ ⑤, 2) a very sensitive CCD camera structures in the animal body. Fluorescence techniques ③, and 3) a bright light source ⑥. Details about these additionally suffer from tissue autofluorescence, result- components will be given in later paragraphs. The dark ing in an unwanted background signal. These negative box was designed in such a way that when the module is features can be partly overcome by using emissions in in ‘open’ position, the handling of the animals in the bed the near-infrared (NIR) spectrum, but unfortunately op- of the U-SPECT is not hampered. When the module is tical imaging cannot equal the detailed view and quanti- ‘closed’, the CCD camera on top of the box is shielded tative accuracy that SPECT provides at larger depths. from ambient light and can produce a total-body top- One of the great challenges today is to place these two view bioluminescent image of the animal via a mirror modalities in perspective and to determine the added ⑪. For photographic and fluorescence imaging, the ani- value of optical imaging within the field of nuclear medi- mal is illuminated by the light source via two optic fibers cine [9]. ④ entering the box and small mirrors ⑩ reflecting the When multimodal tracers with both a radioactive and light onto the bed ①. Excitation and emission light fil- fluorescent signature are used, a single tracer can pro- ters, well adapted to the spectral profile of the fluores- vide ‘best of both worlds’. Such tracers are reported with cent dye under study, can be added to the system. a peptide, monoclonal antibody, or nanoparticle basis For SPECT scans, the animal bed is moved by an XYZ [10-12]. Combined radioactive and fluorescence imaging stage into the U-SPECT ⑨ collimator. For the OI pos- has already provided added value in clinical surgical ition, the bed is held in the same position as used for guidance studies [13,14]. placing an animal in the bed (U-SPECT ‘bed eject pos- Next to the development of multimodal tracers that ition’). Alternatively, by mounting the OI module on a combine two signatures, SPECT and optical modalities separate ‘docking station’, it can also be used as an inde- can also be combined on a single device with a single pendent optical imaging device. The docking station al- user interface. In this way, logistics, including anesthesia, lows for parallel use of the SPECT and OI module. are simplified and may improve animal welfare. Because animal positioning is no longer an issue with respect to Dark box co-registration of the imaging results, the complemen- The dark box uses a rail system to slide over the table, tary value of the different modalities can be exploited to enabling animal placement. The sliding mechanism con- its full extent; e.g. bioluminescent tumor cell localization sists of a U-profile mounted on the box and rails ⑧ combined with tracer distribution imaging (fluorescence mounted on the table that contains the XYZ stage to and/or nuclear). move the bed mounted at the front side of the U- While other groups mainly focus on integrating SPECT. When the box slides to its closed position, it is nuclear imaging with three-dimensional (3D) fluo- lowered by about 1 cm. In this way, the U profiles lock rescence optical tomography (FOT) imaging [15-18] over the rails. Blackboard paint has been applied on the or fluorescence-mediated tomography (FMT) [19], we rails and the U-profile to ensure the light tightness in consider optical imaging, both bioluminescence and locked position. fluorescence, as intrinsically superficial technology, cur- To further block ambient light, all joints on the box rently most suitable for planar imaging. Today, planar have been sealed with Sikaflex-221 (Sika AG, Baar, Zug, imaging is applied in the far majority of optical imaging Switzerland) sealant. Blackboard paint is applied to the studies in preclinical research since optical tomography inside of the box to avoid light reflections. A black ABS- is still highly challenging due to the ill-posed nature of plastic insert ⑦ has been fitted to cover the entrance of optical data caused by strong light absorption and dif- the U-SPECT to prevent leakage of ambient light into fusion [20]. Therefore, we pursued integration of planar the dark box and to avoid reflections from the metallic optical imaging with SPECT.